- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Supreme Enters Negotiations for a Second Medical Marijuana Producing Facility
Supreme Pharmaceuticals Inc. (OTCBB:SPRWF,TSXV:SL) has entered into negotiations to acquire a business and its producing medical marijuana facility. This is in addition to the South Okanagan producing facility currently under evaluation. There is no guarantee an agreement will be reached, but both parties have agreed to a 45-day negotiating period. As quoted in the press release:
Supreme Pharmaceuticals Inc. (OTCBB:SPRWF,TSXV:SL) hasĀ entered into negotiations to acquire a business and its producing medical marijuana facility. This is in addition to the South Okanagan producing facility currently under evaluation. There is no guarantee an agreement will be reached, but both parties have agreed to a 45-day negotiating period. As quoted in the press release:
If Supreme is successful in securing an agreement with this producing company, of which there is no assurance, it will apply for a commercial MMPR licence in regard to this facility, and there is no guarantee that such a license will be granted. The facility is located in the lower mainland of British Columbia and currently operates under MMAP licensing; the business has been producing medical marijuana for several years on wholly owned property.
Supreme CEO, David Stadnyk, said:
Our goal is to secure several medical marijuana producing facilities, each with a MMPR license. There is no assurance that we will be able to secure such facilities. This is a critical year for MMPR licences and we plan on making several applications to Health Canada.
Outlook Reports
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2179.07 | +10.65 | |
Silver | 24.84 | +0.14 | |
Copper | 4.03 | +0.03 | |
Oil | 81.94 | +1.31 | |
Heating Oil | 2.67 | +0.04 | |
Natural Gas | 1.63 | -0.03 |
Investing News Network websites or approved third-party tools use cookies. Please refer to theĀ cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Ā